With the clock ticking, scientists working with human embryonic stem cells were grappling Tuesday with how to use their remaining federal research funds before a court ruling forces them to bring their work to an abrupt end.
Recent Posts
- UCLA researchers engineer experimental drug for preventing heart failure after heart attacks
- Do stem-cell transplants increase cancer risk? Long-lived recipients offer clues
- Re-engineered, blue light-activated immune cells penetrate and kill solid tumors
- Microenvironment-responsive nanomedicines: a promising direction for tissue regeneration
- Life Without Sickle Cell Beckons Boy Who Completed Gene Therapy
- Neuroscientists discover a mechanism that can reactivate dormant neural stem cells